Flutamide

Flutamide and its more potent active metabolite 2-hydroxyflutamide competitively block dihydrotestosterone binding at androgen receptors, forming inactive complexes which cannot translocate into the cell nucleus. Formation of inactive receptors inhibits androgen-dependent DNA and protein synthesis, resulting in tumor cell growth arrest or transient tumor regression. (NCI04). Flutamide has been linked to numerous cases of acute liver injury, which are frequently severe and can be fatal.

General

Type : Trifluoro

Chemical_Nomenclature : 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

Canonical SMILES : CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F

InChI : InChI=1S\/C11H11F3N2O3\/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14\/h3-6H,1-2H3,(H,15,17)

InChIKey : MKXKFYHWDHIYRV-UHFFFAOYSA-N

Other name(s) : Eulexin  ||  Niftolide  ||  Niftholide


MW : 276.21

Formula : C11H11F3N2O3

CAS_number : 13311-84-7

PubChem : 3397

UniChem : MKXKFYHWDHIYRV-UHFFFAOYSA-N

Target

Structures : No structure

Families : Arylacetamide_deacetylase

References (4)

Title : Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver - Kobayashi_2012_Drug.Metab.Dispos_40_1080
Author(s) : Kobayashi Y , Fukami T , Shimizu M , Nakajima M , Yokoi T
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 40 :1080 , 2012
Abstract :
PubMedSearch : Kobayashi_2012_Drug.Metab.Dispos_40_1080
PubMedID: 22446520

Title : Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis - Watanabe_2009_Drug.Metab.Dispos_37_1513
Author(s) : Watanabe A , Fukami T , Nakajima M , Takamiya M , Aoki Y , Yokoi T
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 37 :1513 , 2009
Abstract :
PubMedSearch : Watanabe_2009_Drug.Metab.Dispos_37_1513
PubMedID: 19339378
Gene_locus related to this paper: human-AADAC

Title : Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients - Goda_2006_Drug.Metab.Dispos_34_828
Author(s) : Goda R , Nagai D , Akiyama Y , Nishikawa K , Ikemoto I , Aizawa Y , Nagata K , Yamazoe Y
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 34 :828 , 2006
Abstract :
PubMedSearch : Goda_2006_Drug.Metab.Dispos_34_828
PubMedID: 16507648

Title : [Changes in liver function induced by flutamide in patients with prostate cancer (studies in patients treated with total androgen blockage)] - Ikemoto_2000_Nihon.Hinyokika.Gakkai.Zasshi_91_556
Author(s) : Ikemoto I , Ohishi Y , Yamazaki H , Wada T , Aizawa Y
Ref : Nihon Hinyokika Gakkai Zasshi , 91 :556 , 2000
Abstract :
PubMedSearch : Ikemoto_2000_Nihon.Hinyokika.Gakkai.Zasshi_91_556
PubMedID: 10897581